Corneal antigen presentation: Molecular regulation and functional implications

Ocular Surface

Volumn 3, Issue 4, 2005, Pages S169-S172

  Dana, Reza ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Corneal antigen; Inflammatory response

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CORNEA; CORNEA TRANSPLANTATION; IMMUNOMODULATION; NONHUMAN; PHENOTYPE;

EID: 84949116510     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dana MR, Qian Y, Hamrah P. Emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 2000;19:625-43
2. Dana MR. Corneal antigen-presenting cells: Diversity, plasticity, and disguise. The Cogan Lecture. Invest Ophthalmol Vis Sci 2004;45:722-7
3. Hamrah P, Huq S, Liu Y, et al. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol 2003;4:172-6
4. Hamrah P, Liu Y, Qiang Z, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol 2003;121:1132-40
5. Dana MR, Dai R, Zhu S, et al. Interleukin-1 receptor antagonist suppresses corneal Langerhans cell activity and promotes ocular immune privilege. Invest Ophthalmol Vis Sci 1998;39:70-7
6. Dana MR, Yamada J, Streilein JW. Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation 1997;63:1501-7
7. Yamagami S, Pedram Hamrah P, Dekaris I, et al. The CCR5 chemokine receptor mediates corneal Langerhans cell recruitment. Invest Ophthalmol Vis Sci 2005; in press
8. Dekaris I, Zhu S, Dana MR. Tumor nercrosis factor-alpha regulates corneal Langerhans cell migration. J Immunol 1999;162:4235-9
9. Zhu S, Dana MR. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci 1999;40:1427-34
10. Dekaris I, Yamada J, Streilein JW, Dana MR. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts. Curr Eye Res 1999;19:456-9
11. Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation: current status of basic research and possible future directions in clinical applications. Exp Rev Mol Med 2001;3:1-21
12. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003;22:273-81
13. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor MHC class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Medicine 2002;195:259-68
14. Yamagami S, Dana MR. The critical role of draining lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001;42:1293-8
15. Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to highrisk corneal transplantation. Cornea 2002;21:405-9
16. Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-c on corneal dendritic cells. Am J Path 2003:163:57-68
17. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates dendritic cell migration and induction of immunity to corneal transplants. Nat Med 2004:10:813-5
18. Huq S, Liu Y, Benichou G, Dana MR. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol 2004;173:4464-9
19. Cursiefen C, Chen L, Jackson D, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 2004:45:2666-73